Insider Transactions in Q1 2025 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Saqib Islam Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,672
-0.99%
|
$629,648
$59.92 P/Share
|
|
Feb 14
2025
|
Daniel Lynch Director |
SELL
Open market or private sale
|
Direct |
400
-0.31%
|
$24,000
$60.0 P/Share
|
|
Feb 12
2025
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,186
-1.21%
|
$777,974
$59.28 P/Share
|
|
Feb 12
2025
|
Saqib Islam Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,309
+7.27%
|
-
|
|
Feb 10
2025
|
Daniel Pichl Chief People Officer |
SELL
Open market or private sale
|
Direct |
29,750
-14.23%
|
$1,606,500
$54.81 P/Share
|
|
Feb 10
2025
|
Daniel Pichl Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,750
+17.07%
|
$803,250
$27.64 P/Share
|
|
Feb 10
2025
|
Badreddin Edris Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,000
-13.65%
|
$1,590,000
$53.13 P/Share
|
|
Feb 10
2025
|
Julie Hambleton Director |
SELL
Open market or private sale
|
Direct |
13,774
-77.08%
|
$730,022
$53.01 P/Share
|
|
Feb 10
2025
|
Julie Hambleton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,774
+43.53%
|
$440,768
$32.27 P/Share
|
|
Feb 10
2025
|
Saqib Islam Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
48,000
-4.57%
|
$2,544,000
$53.3 P/Share
|
|
Feb 10
2025
|
Daniel Lynch Director |
SELL
Open market or private sale
|
Direct |
175,000
-24.32%
|
$9,450,000
$54.54 P/Share
|
|
Jan 10
2025
|
Tai An Lin Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,929
+17.34%
|
-
|
|
Jan 10
2025
|
Michael Nofi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,929
+18.45%
|
-
|
|
Jan 10
2025
|
Perier I Francis Jr Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,779
+16.21%
|
-
|
|
Jan 10
2025
|
Daniel Pichl Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,819
+20.16%
|
-
|
|
Jan 10
2025
|
Herschel S Weinstein General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,126
+18.0%
|
-
|
|
Jan 10
2025
|
Bhavesh Ashar Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,323
+21.55%
|
-
|
|
Jan 10
2025
|
James Cassidy Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,323
+17.49%
|
-
|
|
Jan 10
2025
|
Badreddin Edris Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,023
+10.95%
|
-
|
|
Jan 10
2025
|
Saqib Islam Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
74,834
+6.65%
|
-
|
|
Jan 06
2025
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,279
-5.02%
|
$86,602
$38.86 P/Share
|
|
Jan 06
2025
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,284
-4.76%
|
$86,792
$38.86 P/Share
|
|
Jan 06
2025
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,009
-4.08%
|
$38,342
$38.86 P/Share
|
|
Jan 06
2025
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,283
-6.27%
|
$124,754
$38.86 P/Share
|
|
Jan 06
2025
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-4.43%
|
$66,842
$38.86 P/Share
|
|
Jan 06
2025
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,658
-2.51%
|
$63,004
$38.86 P/Share
|
|
Jan 06
2025
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,416
-2.24%
|
$167,808
$38.86 P/Share
|
|
Jan 06
2025
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,359
-1.25%
|
$469,642
$38.86 P/Share
|
|
Jan 05
2025
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,272
-6.72%
|
$124,336
$38.19 P/Share
|
|
Jan 05
2025
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,825
-7.38%
|
$145,350
$38.19 P/Share
|
|
Jan 05
2025
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,636
-6.21%
|
$62,168
$38.19 P/Share
|
|
Jan 05
2025
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,278
-5.89%
|
$124,564
$38.19 P/Share
|
|
Jan 05
2025
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,522
-5.97%
|
$95,836
$38.19 P/Share
|
|
Jan 05
2025
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,465
-4.98%
|
$131,670
$38.19 P/Share
|
|
Jan 05
2025
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,561
-2.74%
|
$211,318
$38.19 P/Share
|
|
Jan 05
2025
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,872
-1.29%
|
$489,136
$38.19 P/Share
|
|
Jan 04
2025
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,575
-6.84%
|
$135,850
$38.19 P/Share
|
|
Jan 04
2025
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,475
-7.94%
|
$170,050
$38.19 P/Share
|
|
Jan 04
2025
|
Tai An Lin Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-3.17%
|
$32,490
$38.19 P/Share
|
|
Jan 04
2025
|
Michael Nofi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,388
-8.31%
|
$90,744
$38.19 P/Share
|
|
Jan 04
2025
|
Perier I Francis Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,582
-6.05%
|
$136,116
$38.19 P/Share
|
|
Jan 04
2025
|
Daniel Pichl Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,988
-6.61%
|
$113,544
$38.19 P/Share
|
|
Jan 04
2025
|
James Cassidy Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-5.86%
|
$164,350
$38.19 P/Share
|
|
Jan 04
2025
|
Badreddin Edris Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,934
-3.31%
|
$263,492
$38.19 P/Share
|
|
Jan 04
2025
|
Saqib Islam Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,469
-1.33%
|
$511,822
$38.19 P/Share
|